Retrospective c-erbB-2 immunostaining in aspiration cytology of breast cancer
β Scribed by M. Jorda; P. Ganjei; M. Nadji
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 334 KB
- Volume
- 11
- Category
- Article
- ISSN
- 8755-1039
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Fifty fineβneedle aspiration cytologies of breast that were diagnosed as carcinomas were retrieved from the files and retrospectively evaluated for the expression of cβ__erb__Bβ2 oncoprotein using standard immunocytochemical methods. Corresponding histologic sections of all tumors were similarly studied.
Seventeen fineβneedle aspirates (34%) reacted positively for the presence of cβ__erb__Bβ2 oncoprotein. All but one (32%) of the corresponding tissue sections were also positive for cβ__erb__Bβ2 by immunohistochemistry. All positive cases were infiltrative ductal carcinomas with a preponderance of the comedo type. Positive reactions were localized in the cytoplasmic membrane of tumor cells. The staining was either present in all cells throughout a tumor, or it was completely absent. We conclude that immunocytochemistry for cβ__erb__Bβ2 oncoprotein can be performed on fineβneedle aspiration cytology samples that are previously fixed and stained with the Papanicolaou technique. Furthermore, the sensitivity of immunostaining results are comparable to that obtained in histologic sections. Diagn Cytopathol 1994; 11:262β265. Β© 1994 WileyβLiss, Inc.
π SIMILAR VOLUMES
The cell-surface receptor tyrosine kinase protein c-erbB-2 is immunocytochemically detected as membrane staining on the surface of cancer cells in 20-30% of cases of breast cancer, and its presence has been associated with poor prognosis for the patient. However, there have been numerous reports of
Most of the data regarding the signijcance of c-erbB-2 oncogene expression as a prognostic marker in breast cancer have been generated in many large retrospective studies by retrieving the corresponding oncoprotein in archival parafin em bedded sections. Recent@. employing fresh breast cancer cells